Rare diseases
Investigational molecules
Locations
Back to Bulgaria40 clinical trials in Pazardzhik, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older
BulgariaSafety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE
BulgariaEvaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
BulgariaA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
BulgariaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
BulgariaStudy on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older
BulgariaStudy of ISIS 678354 for Patients with Severe High Triglycerides
BulgariaStudy of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment
BulgariaStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
BulgariaStudy of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
BulgariaStudy on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for chronic obstructive pulmonary disease (COPD) and asthma, evaluating new therapeutic approaches and medications to improve patient outcomes.
Multiple trials are exploring both established and novel therapeutic options for patients with moderate to severe respiratory conditions.
Groundbreaking research in multiple sclerosis and seizure management, with trials evaluating new therapeutic agents and treatment approaches for various neurological conditions.
Studies are investigating both progressive and relapsing forms of neurological conditions to develop more effective treatments.
Innovative research targeting heart failure and stroke prevention, including studies on new medications for atrial fibrillation and post-stroke care.
These trials aim to improve cardiovascular outcomes and reduce the risk of serious complications in high-risk patients.
Advanced research in schizophrenia and Alzheimer's disease psychosis, focusing on novel therapeutic approaches and long-term treatment solutions.
Trials are exploring new therapeutic options to address both acute symptoms and long-term disease management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
